Fundraising FoxBios Partners — 2022 Investments
2 investments dated 2022 · listed companies and verified rows first · show all
Cue Biopharma is a precision immunotherapy company developing engineered therapies targeting allergic and autoimmune diseases.
BiotechHealthtechMedical DevicesBoston, US
Daniel Baker(Executive Officer)Colin Sandercock(Executive Officer)inDominic Borie(Chief Medical Officer and Head of Research and Development)inSumita Ray(Executive Officer)inMichael Meluzio(Executive Officer)inRodolfo Chaparro(Vice President, Head of Immunology)in
Board seatAaron G.L. Fletcher· per SEC Form D · $30M raise · filed Nov 2022
BiotechAustin, US
James Brian Windsor(President and CEO)Steven Idell(Director)
BoardAaron Fletcher(Director)inJoseph Woelkers(Director)Robert Mills(Director)
Board seatAaron G.L. Fletcher· per SEC Form D
Co-investorsUT Horizon Fund
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.